Merck
MRK
#46
Rank
NZ$488.95 B
Marketcap
NZ$197.77
Share price
0.38%
Change (1 day)
22.74%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$12.54

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$12.47. an increase over its 2024 EPS that were of NZ$11.54.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025NZ$12.437.71%
2024NZ$11.544308.46%
2023NZ$0.26-97.32%
2022NZ$9.7810.92%
2021NZ$8.8284.68%
2020NZ$4.77-27.2%
2019NZ$6.5663.44%
2018NZ$4.01151.11%
2017NZ$1.60-54.58%
2016NZ$3.5230.21%
2015NZ$2.70-61.99%
2014NZ$7.11180.51%
2013NZ$2.53-31.82%
2012NZ$3.726.62%
2011NZ$3.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.01 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.56 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.29 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.46 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.52-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$5.07-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.43-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.12-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel